A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG)
- 7 July 2015
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 34 (4) , 177-183
Abstract
Primary lymphoma of the lung is a rare entity. Clinical features, optimal treatment, role of surgery and outcomes are not well defined, and the follow‐up is variable in published data. Clinical data of 205 patients who were confirmed to have bronchus mucosa‐associated lymphoid tissue lymphoma from December 1986 to December 2011 in 17 different centres worldwide were evaluated. Fifty‐five per cent of the patients were female. The median age at diagnosis was 62 (range 28–88) years. Only 9% had a history of exposure to toxic substances, while about 45% of the patients had a history of smoking. Ten per cent of the patients had autoimmune disease at presentation, and 19% patients had a reported preexisting lung disease. Treatment modalities included surgery alone in 63 patients (30%), radiotherapy in 3 (2%), antibiotics in 1 (1%) and systemic treatment in 128 (62%). Patients receiving a local approach, mainly surgical resection, experienced significantly improved progression‐free survival (p = 0.003) versus those receiving a systemic treatment. There were no other significant differences among treatment modalities. The survival data confirm the indolent nature of the disease. Local therapy (surgery or radiotherapy) results in long‐term disease‐free survival for patients with localized disease. Systemic treatment, including alkylating‐containing regimens, can be reserved to patients in relapse after incomplete surgical excision or for patients with advanced disease. Copyright © 2015 John Wiley & Sons, Ltd.Keywords
Funding Information
- Mayo CCaTS (UL1TRZZZ135)
This publication has 38 references indexed in Scilit:
- Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized StudyJournal of Clinical Oncology, 2013
- Role of Surgery in the Treatment of Primary Pulmonary B-Cell LymphomaThe Annals of Thoracic Surgery, 2007
- Primary Pulmonary LymphomaThe Annals of Thoracic Surgery, 2005
- Primary Pulmonary Non-Hodgkin's LymphomaJapanese Journal of Clinical Oncology, 2004
- Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare diseaseEuropean Journal of Cancer, 2004
- CONSORT statement: extension to cluster randomised trialsBMJ, 2004
- Primary non-Hodgkin’s lymphoma of the lungThe Annals of Thoracic Surgery, 2000
- Is BALT a major component of the human lung immune system?Immunology Today, 1992
- Primary lymphomas of the lung: morphological, immunohistochemical and clinical featuresHistopathology, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958